ABVC
Price
$0.54
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
MRSN
Price
$2.55
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
5 days until earnings call
Ad is loading...

ABVC vs MRSN

Header iconABVC vs MRSN Comparison
Open Charts ABVC vs MRSNBanner chart's image
ABVC BioPharma
Price$0.54
Change-$0.00 (-0.00%)
Volume$89.66K
CapitalizationN/A
Mersana Therapeutics
Price$2.55
Change-$0.00 (-0.00%)
Volume$1.94M
CapitalizationN/A
View a ticker or compare two or three
ABVC vs MRSN Comparison Chart
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABVC vs. MRSN commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and MRSN is a Buy.

COMPARISON
Comparison
Nov 09, 2024
Stock price -- (ABVC: $0.54 vs. MRSN: $2.55)
Brand notoriety: ABVC and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 53% vs. MRSN: 212%
Market capitalization -- ABVC: $6.87M vs. MRSN: $312.82M
ABVC [@Biotechnology] is valued at $6.87M. MRSN’s [@Biotechnology] market capitalization is $312.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 1 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 1 green, 4 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 4 TA indicator(s) are bullish while MRSN’s TA Score has 4 bullish TA indicator(s).

  • ABVC’s TA Score: 4 bullish, 6 bearish.
  • MRSN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MRSN is a better buy in the short-term than ABVC.

Price Growth

ABVC (@Biotechnology) experienced а -21.51% price change this week, while MRSN (@Biotechnology) price change was +40.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +14.64%, and the average quarterly price growth was +11.72%.

Reported Earning Dates

ABVC is expected to report earnings on Nov 13, 2023.

MRSN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($315M) has a higher market cap than ABVC($6.54M). MRSN YTD gains are higher at: 9.914 vs. ABVC (-53.241). ABVC has higher annual earnings (EBITDA): -8.59M vs. MRSN (-99.02M). MRSN has more cash in the bank: 163M vs. ABVC (200K). ABVC has less debt than MRSN: ABVC (2.41M) vs MRSN (32.3M). MRSN has higher revenues than ABVC: MRSN (29.9M) vs ABVC (136K).
ABVCMRSNABVC / MRSN
Capitalization6.54M315M2%
EBITDA-8.59M-99.02M9%
Gain YTD-53.2419.914-537%
P/E RatioN/AN/A-
Revenue136K29.9M0%
Total Cash200K163M0%
Total Debt2.41M32.3M7%
FUNDAMENTALS RATINGS
ABVC vs MRSN: Fundamental Ratings
ABVC
MRSN
OUTLOOK RATING
1..100
8025
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6538
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABVC's Valuation (26) in the null industry is somewhat better than the same rating for MRSN (85) in the Biotechnology industry. This means that ABVC’s stock grew somewhat faster than MRSN’s over the last 12 months.

MRSN's Profit vs Risk Rating (94) in the Biotechnology industry is in the same range as ABVC (100) in the null industry. This means that MRSN’s stock grew similarly to ABVC’s over the last 12 months.

MRSN's SMR Rating (99) in the Biotechnology industry is in the same range as ABVC (99) in the null industry. This means that MRSN’s stock grew similarly to ABVC’s over the last 12 months.

MRSN's Price Growth Rating (38) in the Biotechnology industry is in the same range as ABVC (65) in the null industry. This means that MRSN’s stock grew similarly to ABVC’s over the last 12 months.

MRSN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ABVC (100) in the null industry. This means that MRSN’s stock grew similarly to ABVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVCMRSN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
View a ticker or compare two or three
Ad is loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAMFX5.290.07
+1.34%
Jacob Internet Inv
AGVFX24.240.15
+0.62%
American Funds Global Insight A
JCNRX30.800.16
+0.52%
Janus Henderson Contrarian R
NABCX11.170.03
+0.27%
Neuberger Berman Abs Ret Multi-Mgr C
TSMDX16.88N/A
N/A
Trillium ESG Small/Mid Cap Institutional

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
-1.92%
KNSA - ABVC
40%
Loosely correlated
-0.09%
MRSN - ABVC
33%
Loosely correlated
+8.97%
MLEC - ABVC
31%
Poorly correlated
N/A
FULC - ABVC
27%
Poorly correlated
+1.60%
MDXXF - ABVC
25%
Poorly correlated
+13.08%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with RPTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+8.97%
RPTX - MRSN
43%
Loosely correlated
-3.32%
VRDN - MRSN
41%
Loosely correlated
+1.81%
FATE - MRSN
40%
Loosely correlated
-8.60%
CRNX - MRSN
40%
Loosely correlated
+1.00%
ARDX - MRSN
40%
Loosely correlated
-1.69%
More